Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.indswift.com | |
Market Cap | 115.48 Cr. | |
Enterprise Value(EV) | 1,097.30 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 5.50 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 3.88 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.01 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | -134.41 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | -0.16 | Calculated using Price: 21.32 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.42 Cr. | 54,164,653 Shares |
FaceValue | 2 | |
About Ind-Swift Ltd. | ||
Ind-Swift Limited was incorporated as a public limited company on June 6, 1986 under the Companies Act 1956.It is the flagship company of India based Ind Swift Group. Ind-Swift Limited is a north India based pharmaceutical company. |
1 Day |
|
-3.83% |
1 Week |
|
-20.48% |
1 Month |
|
+10.05% |
3 Month |
|
+18.28% |
6 Month |
|
+37.74% |
1 Year |
|
+141.24% |
2 Year |
|
+80.17% |
5 Year |
|
+306.67% |
10 Year |
|
+216.30% |
5 years | 2016-03 | 2017-03 | 2018-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0 | 0 | 0 | 0 | 0 | |
Return on Capital Employed (%) | -22.84 | -56.7 | -10.34 | 10.83 | 28.45 | |
Return on Assets (%) | -18.95 | -42.37 | -8.46 | -3.21 | 4.07 |
Particulars | 6 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | -245 | -616 | -663 | -720 | -705 | -713 | |
Non Curr. Liab. | 679 | 672 | 680 | 634 | 418 | 424 | |
Curr. Liab. | 621 | 608 | 598 | 718 | 936 | 928 | |
Minority Int. | |||||||
Equity & Liab. | 1,055 | 665 | 615 | 632 | 649 | 639 | |
Non Curr. Assets | 433 | 458 | 429 | 389 | 376 | 373 | |
Curr. Assets | 612 | 206 | 186 | 242 | 273 | 266 | |
Misc. Exp. not W/O | 10 | ||||||
Total Assets | 1,055 | 665 | 615 | 632 | 649 | 639 |
Particulars | 6 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 304 | 263 | 270 | 398 | 411 | 473 | |
Other Income | 13 | 14 | 15 | 24 | 12 | 18 | |
Total Income | 317 | 277 | 284 | 421 | 423 | 491 | |
Total Expenditure | -461 | -328 | -264 | -352 | -369 | -431 | |
PBIDT | -144 | -52 | 21 | 69 | 54 | 60 | |
Interest | -19 | -16 | -11 | -57 | -60 | -63 | |
Depreciation | -36 | -36 | -35 | -32 | -29 | -27 | |
Taxation | 0 | -1 | -1 | 0 | |||
Exceptional Items | -260 | -28 | 1 | 61 | 61 | ||
PAT | -200 | -364 | -54 | -20 | 26 | 30 | |
Minority Interest | |||||||
Share Associate | -14 | -8 | 4 | ||||
Other Related Items | |||||||
Consolidated Net Profit | -214 | -373 | -50 | -20 | 26 | 30 | |
Adjusted EPS | -42 | -69 | -9 | -4 | 5 | 6 |
Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -119 | -2 | 7 | 50 | 73 | |
Cash Fr. Inv. | 10 | 4 | -6 | -18 | -29 | |
Cash Fr. Finan. | 110 | -11 | -6 | -45 | -47 | |
Net Change | 0 | -8 | -5 | -13 | -3 | |
Cash & Cash Eqvt | 17 | 9 | 4 | 16 | 13 |
Wed, 10 Apr 2024
Updates Ind-Swift Limited has informed the Exchange regarding 'Update on Merger of the company with M/s Ind Swift Laboratories Limited (Group Company)'. |
Tue, 09 Apr 2024
Price movement Significant movement in price has been observed in Ind-Swift Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. |
Sat, 06 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Ind-Swift Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
Thu, 18 Apr 2024 |
Opening at Low |
Closing Below Previous Low |
Closing Below Previous Low for 3 days |
Making Lower Lows for 3 days |
Closing Below Previous Low for 2 Days |